HEATHER HUTCHISON: Open Payments
NPI 1265820542 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,977 in 155 payments from 17 companies in 2025. Trend: 2023 $1,255 · 2024 $2,148 · 2025 $2,977
Food & beverage: $2,977
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $676 |
| Madrigal Pharmaceuticals | 10 | $429 |
| Ipsen Biopharmaceuticals, Inc | 14 | $297 |
| Janssen Biotech, Inc. | 15 | $263 |
| PFIZER INC. | 17 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $181 |
| Celltrion USA Inc. | 6 | $144 |
| Regeneron Healthcare Solutions, Inc. | 4 | $137 |
| CSL Behring | 6 | $134 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $96 |
Products named: REZDIFFRA, RINVOQ, IQIRVO, TREMFYA, LINZESS, DUPIXENT, XELJANZ, VEGZELMA.
Industry payments across AR — which companies pay providers there.
